D. Barnett

发表

Cardiac chamber-specific β-adrenoceptor regulation and sympathetic innervation

M. Chester, D. Barnett, 1995, The Lancet.

Beta adrenoceptor density in the donor heart: a guide to prognosis?

M. Chester, D. Barnett, A. Amadi, 1995, British heart journal.

The effect of orthotopic transplantation on total, beta 1- and beta 2-adrenoceptors in the human heart.

M. Yacoub, B. Madden, M. Chester, 1992, British journal of clinical pharmacology.

HETEROGENEITY OF β‐ADRENORECEPTOR SUBTYPES IN THE HUMAN PLACENTA

S. Nahorski, N. Cook, D. Barnett, 1982 .

PROPRANOLOL VERSUS CARBIMAZOLE AS THE SOLE TREATMENT FOR THYROTOXICOSIS. A CONSIDERATION OF CIRCULATING THYROID HORMONE LEVELS AND TISSUE THYROID FUNCTION

B. O'malley, R. Abbott, F. Rosenthal, 1982, Clinical endocrinology.

Direct evidence of two types of β adrenoceptor binding site in lung tissue

D. Barnett, S. Nahorski, E. Rugg, 1978, Nature.

CIRCULATING CATECHOLAMINE, THYROTROPHIN, THYROID HORMONE AND PROLACTIN RESPONSES OF NORMAL SUBJECTS TO ACUTE COLD EXPOSURE

N. Cook, A. Richardson, B. O'malley, 1984, Clinical endocrinology.

A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation

C. Jagger, T. Hassan, D. Barnett, 2002, Emergency medicine journal : EMJ.

(-)-[125I]pindolol binding to the human platelet beta-adrenoceptor: characterisation and agonist interactions.

D. Barnett, S. Nahorski, N. Cook, 1985, European journal of pharmacology.